MMP9 and cardiovascular disorder: It is quite hopeful that the unique structure of SalB, and its relative selectivity towards MMP-9, will enable us to explore the structure-activity relationship to identify more specific and safer MMP-9 inhibitors for the treatment of cardiovascular disease.